Lb Pharmaceuticals Inc.
Clinical trials sponsored by Lb Pharmaceuticals Inc., explained in plain language.
-
New schizophrenia drug enters final testing phase
Disease control Not yet recruitingThis study is testing whether a new medication called LB-102 can help control symptoms during acute schizophrenia episodes. Researchers will compare two different doses of LB-102 against a placebo in 456 adults currently experiencing symptom worsening. The main goal is to see if …
Phase: PHASE3 • Sponsor: LB Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New schizophrenia drug enters final Long-Term safety testing
Disease control Not yet recruitingThis study aims to check the long-term safety and side effects of a new medication called LB-102 for adults with stable schizophrenia. It will involve 900 participants who are not fully satisfied with their current antipsychotic medication and want to switch. The main goal is to …
Phase: PHASE3 • Sponsor: LB Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 04, 2026 15:29 UTC